Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Nöroloji Anabilim Dalı
Son İki Yılda Uluslararası Dergilerde Yayınlanan Makaleler
2024
12. Elvan, Ã.; Esen, K.; KaleaÄŸası, Å.; Tezer, M. Computed Tomography Evaluation of Frontal Sinus Volume in Migraine Patients. JOURNAL OF CRANIOFACIAL SURGERY, 2024, 35, 1110-1113.
10.1097/SCS.0000000000010272
11. öksüz, N. Reliability and Validity Study of the Migraine Interictal Burden Scale-4 in Turkish. NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, 2024, 41, 153-161.
10. öksüz gürlen, N.; Güler aksu, G.; özdemir, A.; özge, A. Internalizing disorders rather than ADHD are risk factors for chronicity in pediatric migraine patients. TURKISH JOURNAL OF MEDICAL SCIENCES, 2024, 54, 930-937.
9. öksüz gürlen, N.; Ghouri, R.; Taşdelen, B.; Uludüz, D.; özge, A. Mild Cognitive Impairment Progression and Alzheimer’s Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months. JOURNAL OF CLINICAL MEDICINE, 2024, 13, -.
2023
8. özge, A.; Ghouri, R.; öksüz gürlen, N.; Taşdelen, B. Early intervention and adding effective doses of EGb761 like Ginkgo extract slow down dementia progression: insights to the neurovascular unit. FRONTIERS MEDIA SA, 2023, 14, 1-18.
7. özge, A.; Ghouri, R.; öksüz gürlen, N.; Taşdelen, B. Predictive factors for Alzheimer’s disease progression: a comprehensive retrospective analysis of 3,553 cases with 211 months follow-up. FRONTIERS MEDIA SA, 2023, 14, 1239995-1239995.
6. Ghouri, R.; öksüz gürlen, N.; Taşdelen, B.; özge, A. Factors affecting progression of non-Alzheimer dementia: a retrospective analysis with long-term follow-up. FRONTIERS MEDIA SA, 2023, 14, 1240093-1240093.
5. öksüz gürlen, N.; özge, A. Gray zones in the trigeminal autonomic cephalalgias. NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, 2023, 40, 15-19.
4. Yetkin, D.; Yılmaz, Ä.; Ayaz, F. Anti-inflammatory activity of bupropion through immunomodulation of the macrophages. NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY, 2023, 396, 2087-2093.
3. öksüz, N. Real-life experiences with galcanezumab and predictors for treatment response in Turkey. SPRINGER SCIENCE AND BUSINESS MEDIA LLC, 2023, 23, 418-418.
2. öksüz, N. One Patient, Three Providers: A Multidisciplinary Approach to Managing Common Neuropsychiatric Cases. MDPI AG, 2023, 12, 5754-5754.
1. öksüz gürlen, N.; Kömür, M.; Doğu, O. Treatment Dilemma in a Juvenile Huntington’s patient presenting with psychiatric symptoms. NÖROPSIKIYATRI ARŞIVI, 2023, 60, 87-89.
